Implementation Guide CH VACD
5.0.0 - trial-use
This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Generated Narrative: Immunization TCA02-IMMUN4-HCP2-ORG2-ROLE
Author of the content: PractitionerRole
CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/1829245678
status: Completed
vaccineCode: Havrix 1440
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-08-20
recorded: 2021-08-20 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use
Actor |
PractitionerRole |
TargetDisease | DoseNumber[x] |
Viral hepatitis, type A (disorder) | 2 |